Pharma Focus America

Coronavirus Drug Discovery

Coronavirus Drug Discovery

Pages: 406

Publisher: Elsevier

Year of Publication: 2022

Author(s) : Chukwuebuka Egbuna

Book Description:

Coronavirus Drug Discovery, Volume Three: Druggable Targets and In Silico Update provides a comprehensive overview of drug discovery efforts targeting COVID-19. The first part of the volume covers various druggable targets and associated signaling pathways for effective targeting of SARS-CoV-2. The second part focuses on computational approaches and in silico studies against SARS-CoV-2. Written by a global team of experts, this book serves as an invaluable resource for drug developers, medicinal chemists, pharmaceutical companies engaged in research and development, academic and industry research institutes, as well as healthcare organizations such as the National Library of Medicines and Health. Additionally, regulatory agencies including the National Institutes of Health, Centers for Disease Control and Prevention, World Health Organization, European Medicines Agency, and the US Food and Drug Administration, among others involved in COVID-19 drug discovery, will benefit from the insights provided in this book.

Thermo Fisher Scientific - mRNA ServicesFuture Labs Live USA 2024World Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies USA 2024World Orphan Drug Congress Europe 2024